As IBD is associated with disruption of the intestinal microbiome (dysbiosis), it is necessary to establish whether the disease is associated with increased amounts of PPAR-γ-activating bacteria, especially in the presence of abnormal body weight. This evidence concerns the gene PPARG and inflammatory bowel disease.